Reply: Hepatic steatosis and glycemic burden in chronic hepatitis B

Lung-Yi Mak^{1

2}, Man-Fung Yuen^{1

2}, Wai-Kay Seto^{1

2}

Affiliations

¹ Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.
² State Key Laboratory of Liver Research, The University of Hong Kong, Pok Fu Lam, Hong Kong.

Comment

Lung-Yi Mak et al. Hepatology. 2023.

. 2023 Jul 1;78(1):E12-E13.

doi: 10.1097/HEP.0000000000000374. Epub 2023 Mar 22.

Lung-Yi Mak^{1

2}, Man-Fung Yuen^{1

2}, Wai-Kay Seto^{1

2}

¹ Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.
² State Key Laboratory of Liver Research, The University of Hong Kong, Pok Fu Lam, Hong Kong.

No abstract available

Comment on

Glycemic burden and the risk of adverse hepatic outcomes in patients with chronic hepatitis B with type 2 diabetes.
Mak LY, Hui RW, Lee CH, Mao X, Cheung KS, Wong DK, Lui DT, Fung J, Yuen MF, Seto WK. Mak LY, et al. Hepatology. 2023 Feb 1;77(2):606-618. doi: 10.1002/hep.32716. Epub 2022 Sep 21. Hepatology. 2023. PMID: 36130882
Letter to the Editor: Hepatic steatosis and glycemic burden in chronic hepatitis B.
Huang SC, Kao JH. Huang SC, et al. Hepatology. 2023 Jul 1;78(1):E11. doi: 10.1097/HEP.0000000000000371. Epub 2023 Mar 20. Hepatology. 2023. PMID: 36929778 No abstract available.

1. Huang S-C, Kao J-H. Letter to the Editor: Hepatic steatosis and glycemic burden in chronic hepatitis B. Hepatology. 2023. doi:10.1097/HEP.0000000000000371 - DOI
1. Mak LY, Hui RWH, Lee CH, Mao X, Cheung KS, Wong DKH, et al. Glycemic burden and the risk of adverse hepatic outcomes in patients with chronic hepatitis B with type 2 diabetes. Hepatology. 2023;77:606–618.
1. Mak LY, Hui RWH, Fung J, Liu F, Wong DKH, Cheung KS, et al. Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B. J Hepatol. 2020;73:800–806.
1. Mak LY, Hui RWH, Fung J, Liu F, Wong DKH, Li B, et al. Reduced hepatic steatosis is associated with higher risk of hepatocellular carcinoma in chronic hepatitis B infection. Hepatol Int. 2021;15:901–911.